PT UBC Medical Indonesia Tbk (IDX:LABS)
Indonesia · Delayed Price · Currency is IDR 144.00
+3.00 (2.13%)
Feb 9, 2026, 4:06 PM WIB
IDX:LABS Revenue
PT UBC Medical Indonesia Tbk had revenue of 48.74B IDR in the quarter ending September 30, 2025, with 16.34% growth. This brings the company's revenue in the last twelve months to 176.64B. In the year 2024, PT UBC Medical Indonesia Tbk had annual revenue of 147.64B with 8.00% growth.
Revenue (ttm)
176.64B
Revenue Growth
+8.00%
P/S Ratio
3.22
Revenue / Employee
2.85B
Employees
62
Market Cap
568.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 147.64B | 10.94B | 8.00% |
| Dec 31, 2023 | 136.70B | 43.41B | 46.53% |
| Dec 31, 2022 | 93.29B | -36.67B | -28.22% |
| Dec 31, 2021 | 129.96B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition